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Introduction
FMF is associated with pulmonary hypertension(PH)
due to amyloidosis. However, clinically overt PH with
right-sided heart failure remains a rare event limited to
few patients with pulmonary amyloidosis secondary to
FMF. We report two cases of FMF patients, with and
without amyloidosis, who experienced PH with right-
sided heart failure. To our knowledge, this is the first
case report on cor pulmonale in FMF patient without
amyloidosis.
Case report
First
A.R.,72 year old non-smoker male presented with
6-month history of cough, dyspnea and intensive weight
loss (8 kg). He had typical FMF abdominal and chest
attacks since the age of 28. He took colchicine irregu-
larly,during attacks only. He gave a positive family his-
tory. His daughter (40,has had FMF attacks since the
age of 35) and cousin brothers were also affected. No
history of occupational exposure. Series of X-ray and
thoracic CT scan demonstrated unilateral ground-glass
opacities in a basal segment of right lung and cardiome-
galy. Echocardiography showed hypertrophy of left ven-
tricle, dilated right ventricle, tricuspid regurgitation, and
PH, findings compatible with cor pulmonale. Upper GI
endoscopy with gastric biopsy revealed atrophic gastritis.
Laboratory investigations revealed: CRP 79.2mg/L, SAA
210g/L, creatinin 162.1-189μmol/l and proteinuria
0.19g/daily. Two months later patient died of heart fail-
ure. Postmortem examination showed emphysema, lung
fibrosis and sclerosis, myocardial hypertrophy and kid-
ney arteriolosclerosis. Daughter’s genetic test revealed
one mutation in exon 2 in the heterozygous state
E148Q/N.
Second
S.H.,47 year old male, a smoker, presented with cough,
progressive dyspnea and pedal edema. He had typical
FMF abdominal and chest attacks since early childhood.
He gave a positive family history. His sister and brother
were also affected. He took colchicine irregularly, during
attacks only. Genetic test showed compound heterozygos-
ity (M694V M680IG/C). ElectroKG showed atrial fibrilla-
tion and low QRS voltage in the limb leads. Doppler
ECG demonstrated biventricular wall thickening, dilated
right ventricle, diastolic dysfunction, and pulmonary
hypertension. Laboratory investigations revealed: creatinin
172.4μmol/l, proteinuria 1.4g/daily. CT demonstrated dif-
fuse interstitial lung infiltrates and bullas (marked air
cysts). Eight months later, patient died of heart failure.
Postmortem examination showed extensive deposits of
amyloid in the kidneys, pulmonary vasculature, alveolar
septa, pleura and myocardium.
Discussion
FMF patients with chest attacks may develop PH. If pre-
sent, PH is a sign of advanced disease, and the survival
rate after diagnosis is low. A diagnosis of PH should be
considered in patients with and without amyloidosis and
unexplained dyspnea or fluid overload. Although pul-
monary involvement may occur in FMF, PH with right
sided heart failure is considered an infrequent diagnosis
and is rarely the cause of death.
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